tiprankstipranks
Cellectis SA (CLLS)
NASDAQ:CLLS

Cellectis SA (CLLS) Technical Analysis

851 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Cellectis SA’s (CLLS) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Cellectis SA is a Buy.
Cellectis SA’s (CLLS) 20-Day exponential moving average is 2.80, while Cellectis SA’s (CLLS) share price is $2.6, making it a Sell.
Cellectis SA’s (CLLS) 50-Day exponential moving average is 2.83, while Cellectis SA’s (CLLS) share price is $2.6, making it a Sell.

Cellectis SA (CLLS) Pivot Points

Mar 05, 2024, 08:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.45
2.49
2.53
2.57
2.61
2.65
2.69
Fibonacci
2.49
2.52
2.54
2.57
2.60
2.62
2.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectis SA (CLLS) Moving Averages

Mar 05, 2024, 08:44 AM
Period
Simple
Exponential
MA5
2.64Buy
2.66Sell
MA10
2.74Sell
2.72Sell
MA20
2.85Sell
2.80Sell
MA50
2.95Sell
2.83Sell
MA100
2.63Buy
2.67Sell
MA200
2.27Buy
2.38Buy
Cellectis SA’s (CLLS) 10-Day exponential moving average is 2.72, while Cellectis SA’s (CLLS) share price is $2.6, making it a Sell.
Cellectis SA’s (CLLS) 100-Day exponential moving average is 2.67, while Cellectis SA’s (CLLS) share price is $2.6, making it a Sell.
Cellectis SA’s (CLLS) stock price is $2.6 and Cellectis SA’s (CLLS) 50-day simple moving average is 2.95, creating a Sell signal.
Cellectis SA’s (CLLS) stock price is $2.6 and Cellectis SA’s (CLLS) 100-day simple moving average is 2.63, creating a Buy signal.
Cellectis SA’s (CLLS) stock price is $2.6 and Cellectis SA’s (CLLS) 200-day simple moving average is 2.27, creating a Buy signal.

Cellectis SA (CLLS) Technical Indicators

Mar 05, 2024, 08:44 AM
Name
Value
Implied Action
RSI (14)
41.38
Neutral
STOCH (9,6)
16.32
Buy
STOCHRSI (14)
12.05
Buy
MACD (12,26)
-0.08
Buy
ADX (14)
15.84
Buy
Williams %R
-77.19
Buy
CCI (14)
-129.16
Buy
ATR (14)
0.15
-
Ultimate Oscillator
52.64
Neutral
ROC
-13.40
Sell
Cellectis SA’s (CLLS) Relative Strength Index (RSI) is 41.38, creating a Neutral signal.
Cellectis SA’s (CLLS) Trend Strength Indicator (ADX) is 15.84, creating a Buy signal.
Cellectis SA’s (CLLS) Commodity Channel Index (CCI) is -129.16, creating a Buy signal.
Cellectis SA’s (CLLS) Price Rate of Change (ROC) is -13.40, creating a Sell signal.

FAQ

Is CLLS a Buy, Hold, or Sell?
Based on CLLS’s technical indicators, CLLS is a Hold.
    What is CLLS’s RSI (14)?
    CLLS’s RSI (14) is 41.38, which suggests CLLS is a Neutral.
      What is CLLS’s MACD?
      CLLS’s MACD is -0.08, which suggests CLLS is a Buy.
        What is CLLS’s 5-day moving average?
        CLLS’s 5-day moving average is 2.64, which suggests CLLS is a Buy.
          What is CLLS’s 20-day moving average?
          CLLS 20-day moving average is 2.85, which suggests CLLS is a Sell.
            What is CLLS’s 50-day moving average?
            CLLS’s 50-day moving average is 2.95, which suggests CLLS is a Sell.
              What is CLLS’s 200-day moving average?
              CLLS’s 200-day moving average is 2.27, which suggests CLLS is a Buy.
                What is CLLS’s Williams % R (14)?
                CLLS’s Williams % R (14) is -77.19, which suggests CLLS is a Buy.
                  What is CLLS’s CCI (14)?
                  CLLS’s CCI (14) is -129.16, which suggests CLLS is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis